共 34 条
- [2] [Anonymous], 2021, PATIENT REGISTRY ANN
- [4] Borawska-Kowalczyk Urszula, 2015, Dev Period Med, V19, P127
- [7] ceddcozum, US
- [9] A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation [J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 68 - 77
- [10] Deming WE., 1982, OUT CRISIS